St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in …

St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in …
ST. PAUL, Minn.—-St. Jude Medical, Inc. , a global medical device company, announced today at EuroPCR that the first patient was enrolled in the FAME II (Fractional Flow Reserve -Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment vs.

Read more on Business Wire via Yahoo! Finance

More Meth Drug Addiction Info:

• Sovereign bonds and wealth funds–Short On Cash Flow
• ArkayCareers.com – Medical News » Blog Archive » St. Jude Medical …
• NTRO Announces Over 93k Of Crude Oil in Strong Reserve Calculation …
• Top Medical Device Companies in 2010 : Medical Sales Recruiter …
• NovoStent Announces 6-Month Results Of SAMBA Femoropopliteal Trial …
• SpectraScience Appoints Sheldon L. Miller Esq. to Its Board of …
• Medical Devices & The Kenyan Constitution | Kenyanentrepreneur.com
• Simulation and Mathematical Analysis of Optimal Power Flow in …
• Volcano Progresses With OCT | Daily Markets
• Who cares what they are called? – St. Paul, MN Photos